Investors are on the edge of their collective seats, hoping that Cooper
What analysts say:
- Buy, sell, or hold?: Analysts strongly back Cooper, with five out of eight rating it a buy and the remainder rating it a hold. Analysts like Cooper better than competitor Teleflex overall. Analysts haven't adjusted their rating of Cooper for the past three months.
- Revenue forecasts: On average, analysts predict $317.1 million in revenue this quarter. That would represent a rise of 8.2% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $1.03 per share. Estimates range from $0.97 to $1.09.
What our community says:
CAPS All-Stars are split on Cooper, with 54.8% rating it an outperform and 45.2% giving it an underperform rating. Cooper's bearish CAPS rating of two out of five stars falls short of the Fool community sentiment.
Cooper's profit has risen year over year by an average of more than threefold over the past five quarters. The company upped its gross margin by 2.1 percentage points in the last quarter. Revenue rose 15.2% while cost of sales rose 9.1% to $137.3 million from a year earlier.
For all our Cooper-specific analysis, including earnings and beyond, add Cooper to My Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.Earnings estimates provided by Zacks.
More from The Motley Fool
Cooper Companies Inc Stock Is Sinking On Disappointing Fourth-Quarter Results
The medical-device maker's stock headed lower today after missing the Street's earnings expectations for the fourth quarter.
5 Reasons to Buy This Health Care Stock -- and Why to Avoid It
A close look at Cooper Companies.
Cooper Leveraging Share Gains for Eye-Opening Growth
Though not cheap, Cooper could be positioning for some significant revenue, margin, and cash flow improvements.